Jager A - Search Results

1

Changes in survival in de novo metastatic cancer in an era of new medicines.

Luyendijk M, Visser O, Blommestein HM, de Hingh IHJT, Hoebers FJP, Jager A, Sonke GS, de Vries EGE, Uyl-de Groot CA, Siesling S. Luyendijk M, et al. Among authors: jager a. J Natl Cancer Inst. 2023 Jun 8;115(6):628-635. doi: 10.1093/jnci/djad020. J Natl Cancer Inst. 2023. PMID: 36978244 Free PMC article.

2

The efficacy of taxane chemotherapy for metastatic breast cancer in BRCA1 and BRCA2 mutation carriers.

Kriege M, Jager A, Hooning MJ, Huijskens E, Blom J, van Deurzen CH, Bontenbal M, Collee JM, Menke-Pluijmers MB, Martens JW, Seynaeve C. Kriege M, et al. Among authors: jager a. Cancer. 2012 Feb 15;118(4):899-907. doi: 10.1002/cncr.26351. Epub 2011 Jul 14. Cancer. 2012. PMID: 21761396 Free article.

3

Adjuvant systemic therapy in early breast cancer: impact of guideline changes and clinicopathological factors associated with nonadherence at a nation-wide level.

Verschoor AM, Kuijer A, Verloop J, Van Gils CH, Sonke GS, Jager A, van Dalen T, Elias SG. Verschoor AM, et al. Among authors: jager a. Breast Cancer Res Treat. 2016 Sep;159(2):357-65. doi: 10.1007/s10549-016-3940-7. Epub 2016 Aug 12. Breast Cancer Res Treat. 2016. PMID: 27514397

4

Clinical auditing as an instrument for quality improvement in breast cancer care in the Netherlands: The national NABON Breast Cancer Audit.

van Bommel AC, Spronk PE, Vrancken Peeters MT, Jager A, Lobbes M, Maduro JH, Mureau MA, Schreuder K, Smorenburg CH, Verloop J, Westenend PJ, Wouters MW, Siesling S, Tjan-Heijnen VC, van Dalen T; NABON Breast Cancer Audit. van Bommel AC, et al. Among authors: jager a. J Surg Oncol. 2017 Mar;115(3):243-249. doi: 10.1002/jso.24516. Epub 2016 Nov 25. J Surg Oncol. 2017. PMID: 27885679

5

Breast Cancer Survival of BRCA1/BRCA2 Mutation Carriers in a Hospital-Based Cohort of Young Women.

Schmidt MK, van den Broek AJ, Tollenaar RA, Smit VT, Westenend PJ, Brinkhuis M, Oosterhuis WJ, Wesseling J, Janssen-Heijnen ML, Jobsen JJ, Jager A, Voogd AC, van Leeuwen FE, van 't Veer LJ. Schmidt MK, et al. Among authors: jager a. J Natl Cancer Inst. 2017 Aug 1;109(8). doi: 10.1093/jnci/djw329. J Natl Cancer Inst. 2017. PMID: 28376189

6

Omitting re-excision for focally positive margins after breast-conserving surgery does not impair disease-free and overall survival.

Vos EL, Siesling S, Baaijens MHA, Verhoef C, Jager A, Voogd AC, Koppert LB. Vos EL, et al. Among authors: jager a. Breast Cancer Res Treat. 2017 Jul;164(1):157-167. doi: 10.1007/s10549-017-4232-6. Epub 2017 Apr 7. Breast Cancer Res Treat. 2017. PMID: 28389735 Free PMC article.

7

The influence of socioeconomic status and ethnicity on adjuvant systemic treatment guideline adherence for early-stage breast cancer in the Netherlands.

Kuijer A, Verloop J, Visser O, Sonke G, Jager A, van Gils CH, van Dalen T, Elias SG. Kuijer A, et al. Among authors: jager a. Ann Oncol. 2017 Aug 1;28(8):1970-1978. doi: 10.1093/annonc/mdx204. Ann Oncol. 2017. PMID: 28459994 Free article.

8

Potential cost savings owing to the route of administration of oncology drugs: a microcosting study of intravenous and subcutaneous administration of trastuzumab and rituximab in the Netherlands.

Franken MG, Kanters TA, Coenen JL, de Jong P, Koene HR, Lugtenburg PJ, Jager A, Uyl-de Groot CA. Franken MG, et al. Among authors: jager a. Anticancer Drugs. 2018 Sep;29(8):791-801. doi: 10.1097/CAD.0000000000000648. Anticancer Drugs. 2018. PMID: 29846248

9

Selecting the optimal position of CDK4/6 inhibitors in hormone receptor-positive advanced breast cancer - the SONIA study: study protocol for a randomized controlled trial.

van Ommen-Nijhof A, Konings IR, van Zeijl CJJ, Uyl-de Groot CA, van der Noort V, Jager A, Sonke GS; SONIA study steering committee. van Ommen-Nijhof A, et al. Among authors: jager a. BMC Cancer. 2018 Nov 20;18(1):1146. doi: 10.1186/s12885-018-4978-1. BMC Cancer. 2018. PMID: 30458732 Free PMC article.

10

Transformation of the National Breast Cancer Guideline Into Data-Driven Clinical Decision Trees.

Hendriks MP, Verbeek XAAM, van Vegchel T, van der Sangen MJC, Strobbe LJA, Merkus JWS, Zonderland HM, Smorenburg CH, Jager A, Siesling S. Hendriks MP, et al. Among authors: jager a. JCO Clin Cancer Inform. 2019 May;3:1-14. doi: 10.1200/CCI.18.00150. JCO Clin Cancer Inform. 2019. PMID: 31141422 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,011 results

Search Page